Type I and II endometrial cancers: have they different risk factors?
暂无分享,去创建一个
M. Pike | J. Cerhan | P. A. van den Brandt | C. Friedenreich | M. García-Closas | T. Rebbeck | M. McCullough | A. Wolk | K. Courneya | B. Henderson | A. Spurdle | L. Kolonel | S. Hankinson | J. Freudenheim | X. Shu | Y. Xiang | H. Anton-Culver | L. Brinton | J. Lissowska | H. Cai | M. Goodman | F. Ricceri | B. Strom | L. Bernstein | A. Miller | T. Rohan | K. K. van de Vijver | N. Wentzensen | P. Horn-Ross | N. Weiss | K. Anderson | K. Robien | S. Olson | H. Risch | Herbert Yu | C. Schairer | S. Polidoro | C. Sacerdote | Yikyung Park | J. Lacey | R. Matsuno | L. Schouten | K. Moysich | S. McCann | X. Liang | I. De Vivo | Hannah P. Yang | A. Magliocco | R. Soslow | Chu Chen | V. Setiawan | J. Doherty | P. Webb | N. Håkansson | L. Cook | G. Lurie | M. Gaudet | Lingeng Lu | P. Thompson | J. Prescott | R. Rastogi | P. Horn‐Ross | Radhai Rastogi | B. Henderson
[1] M. Sherman,et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[2] J. V. Bokhman. Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.
[3] M. Pike,et al. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.
[4] C. Mantzoros,et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis , 2007, Diabetologia.
[5] M. Thun,et al. Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype , 2008, Cancer Epidemiology Biomarkers & Prevention.
[6] J. Cerhan,et al. Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] C. Friedenreich,et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.
[8] E. Oliva,et al. Molecular Profile of Grade 3 Endometrioid Endometrial Carcinoma: Is it a Type I or Type II Endometrial Carcinoma? , 2012, The American journal of surgical pathology.
[9] George L Mutter,et al. Molecular and pathologic aspects of endometrial carcinogenesis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Taylor,et al. Cigarette Smoke Increases Progesterone Receptor and Homeobox A10 Expression in Human Endometrium and Endometrial Cells: A Potential Role in the Decreased Prevalence of Endometrial Pathology in Smokers1 , 2011, Biology of reproduction.
[11] I. Gram,et al. Risk of endometrial cancer in relationship to cigarette smoking: Results from the EPIC study , 2007, International journal of cancer.
[12] F. Berrino,et al. Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer , 2004, International journal of cancer.
[13] J. Prat,et al. Endometrial carcinoma: pathology and genetics. , 2007, Pathology.
[14] R. Knapp,et al. Cigarette smoking and the risk of endometrial cancer. , 1985, The New England journal of medicine.
[15] Shannon M. Lynch,et al. Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Causes & Control.
[16] E. Calle,et al. Doctors and climate change , 2007, BMJ : British Medical Journal.
[17] G. Emons,et al. Hormonal interactions in endometrial cancer. , 2000, Endocrine-related cancer.
[18] J. Clore,et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. , 1991, The Journal of clinical endocrinology and metabolism.
[19] Bin Wang,et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. , 2008, The American journal of medicine.
[20] G. Schaller,et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. , 2012, Gynecologic oncology.
[21] R. Soslow. Endometrial carcinomas with ambiguous features. , 2010, Seminars in diagnostic pathology.
[22] A. Nickles Fader,et al. Uterine Papillary Serous Carcinoma , 2011, Clinical obstetrics and gynecology.
[23] M. García-Closas,et al. Active and passive cigarette smoking and the risk of endometrial cancer in Poland. , 2010, European journal of cancer.
[24] R. Stone,et al. Factors associated with Type I and Type II endometrial cancer , 2010, Cancer Causes and Control.
[25] R. Kaaks,et al. Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .
[26] M. Sherman. Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach , 2000, Modern Pathology.
[27] Gretchen L. Gierach,et al. Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. , 2013, American journal of epidemiology.
[28] A. Lukanova,et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study , 2011 .
[29] G. Colditz,et al. Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study , 2005, International journal of cancer.
[30] E. Weiderpass,et al. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women , 2007, International journal of cancer.